Endothelial damage inhibitors for improvement of saphenous vein graft patency in coronary artery bypass grafting
Sandner, Sigrid E.
Aschacher, Thomas
Pachuk, Catherine J.
Milojević, Milan
Caliskan, Etem
Emmert, Maximilian Y.
The saphenous vein graft (SVG) remains the most commonly used conduit in coronary artery bypass grafting (CABG). In light of this further research must be aimed at the development of strategies to optimize SVG patency and thereby improve both short- and long-term outcomes of CABG surgery. SVG patency in large part depends on the protection of the structural and functional integrity of the vascular endothelium at the time of conduit harvesting, including optimal storage conditions to prevent endothelial damage. This review provides an overview of currently available storage and preservation solutions, including novel endothelial damage inhibitors, and their role in mitigating endothelial damage and vein graft failure.
engleski
2020
© All rights reserved
Key words: coronary artery bypass, saphenous vein, coronary artery disease, vascular grafting